World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Switzerland
2026
Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Microbiology

D-Index
103
Citations
46317
World Ranking
343
National Ranking
7

Medicine

D-Index
103
Citations
47074
World Ranking
7256
National Ranking
101

Research.com Recognitions

  • 2026 - Research.com Microbiology in Switzerland Leader Award
  • 2025 - Research.com Microbiology in Switzerland Leader Award
  • 2023 - Research.com Medicine in Switzerland Leader Award
  • 2022 - Research.com Microbiology in Switzerland Leader Award
  • 2016 - Member of Academia Europaea

Overview

Manuel Battegay is affiliated with the University Hospital of Basel in Switzerland and has contributed extensively to research in medicine, focusing on infectious diseases, epidemiology, and virology. Their work encompasses several key subfields including Emergency Medicine and Pediatrics, Perinatology and Child Health.

The main topics of Manuel Battegay's research center on HIV/AIDS and COVID-19, covering various aspects such as:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV, Drug Use, Sexual Risk

Among the frequent co-authors working alongside Manuel Battegay are:

  • Matthias Cavassini
  • Enos Bernasconi
  • Huldrych F. Günthard
  • Catia Marzolini
  • Alexandra Calmy

Their publications are commonly found in leading journals and publication venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases
  • Zenodo (CERN European Organization for Nuclear Research)

Recent papers authored or co-authored by Manuel Battegay include:

  • "COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation," 2020, Swiss Medical Weekly
  • "2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution," 2020, Swiss Medical Weekly
  • "Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray," 2021, Nature Communications
  • "2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0," 2020, HIV Medicine
  • "Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)," 2021, International Journal of Epidemiology

Manuel Battegay's contributions have been recognized with memberships in scientific communities, notably as a Member of Academia Europaea, an honor received in 2016.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

    R Hogg;V Lima;J Sterne;S Grabar

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

    Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai

  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

    Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob

  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

    Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.

    Matthias Egger;Bernard Hirschel;Patrick Francioli;Philippe Sudre

  • Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

    Barbara Hasse;Bruno Ledergerber;Hansjakob Furrer;Manuel Battegay

  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  • Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.

    Manuel Battegay;Sue Cooper;Alana Althage;Jürg Bänziger

  • COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.

    Marcel Salathé;Christian L Althaus;Richard Neher;Silvia Stringhini

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

    Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer

  • Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

    R Weber;M Ruppik;M Rickenbach;A Spoerri

  • Immune Reconstitution in HIV-Infected Patients

    Hans H Hirsch;Gilbert Kaufmann;Pedram Sendi;Manuel Battegay

  • Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

    Heiner C. Bucher;Lauren E. Griffith;Gordon H. Guyatt;Philippe Sudre

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

    M Battegay;D Moskophidis;A Rahemtulla;H Hengartner

  • Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

    Hansjakob Furrer;Matthias Egger;Milos Opravil;Enos Bernasconi

  • Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs

    Thomas M. Kündig;Thomas M. Kündig;Martin F. Bachmann;Claudio DiPaolo;John J. L. Simard

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

Frequent Co-Authors

Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Hansjakob Furrer
Hansjakob Furrer University of Bern
Matthias Cavassini
Matthias Cavassini University of Lausanne
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Rainer Weber
Rainer Weber University of Zurich
Heiner C. Bucher
Heiner C. Bucher University Hospital of Basel
Thomas Klimkait
Thomas Klimkait University of Basel
Andreas F. Widmer
Andreas F. Widmer University Hospital of Basel
Hans H. Hirsch
Hans H. Hirsch University Hospital of Basel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career pathways, many of which now offer flexible online education options. For those interested in expanding their healthcare knowledge remotely, exploring online healthcare programs can be a great starting point. These programs often include interdisciplinary courses that complement a microbiology background.

If public health appeals to you, pursuing an online Master of Public Health (MPH) is a popular choice. Finding the easy MPH online programs to get into can help streamline your education while maintaining quality and accreditation.

Career options extend beyond traditional lab roles. For example, becoming a child life specialist involves supporting children’s emotional well-being, and understanding the child life specialist salary is crucial when considering this rewarding profession.

Additionally, microbiology graduates with past legal challenges may find encouragement in the availability of the best degrees for felons, allowing them to pursue meaningful careers while overcoming barriers.

Best Scientists Citing Manuel Battegay

Trending Scientists